adalimumab
abbvie,coherus
['adalimumab', 'coherus']
attending #acr22? don't forget to join us for our poster session today at 1 pm pt to learn more about the safety and efficacy of adalimumab biosimilars. #acr22 see our accepted abstract here: 
Leader in developing and commercializing high-quality, high-value biosimilar therapeutics.